Products, vehicles, drugs and devices showing sharply rising complaint velocity — a leading indicator of recall risk, often weeks before any official action. Built on public CPSC, openFDA and NHTSA complaint data.
We backtested complaint-velocity against official recalls. Here is exactly how calibrated it is — including how often it's wrong. Sold as risk-triage, never as a prediction.
Ranked by complaint-velocity risk score. Last computed: 2026-08-05 07:22 UTC.
| # | Entity | Band | Risk | Vel /wk | vs base | Accel /wk | Severe | 30d |
|---|---|---|---|---|---|---|---|---|
| 1 | Chevrolet Bolt EV (2022) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (100%) |
LOW | 34 | 0.23 | 3× | 0 | 0% | 1 |
| 2 | Chevrolet Blazer EV (2024) vehicle · nhtsa · backtested ↑ FORWARD COLLISION AVOIDANCE (40%) |
LOW | 32 | 0.7 | 1.5× | -0.47 | 38% | 3 |
| 3 | Kia EV6 (2023) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (57%) |
LOW | 29 | 0.93 | 1.71× | 0.23 | 0% | 4 |
| 4 | Tesla Model 3 (2023) vehicle · nhtsa · backtested ↑ STRUCTURE (100%) |
LOW | 18 | 0.23 | 0.17× | -2.33 | 42% | 1 |
| 5 | Ford Mustang Mach-E (2022) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (17%) |
BASELINE | 17 | 0.47 | 0.55× | 0.23 | 67% | 2 |
| 6 | Tesla Model Y (2023) vehicle · nhtsa · backtested ↑ SUSPENSION (19%) |
BASELINE | 17 | 3.97 | 1.19× | 0 | 18% | 17 |
| 7 | Tesla Cybertruck (2024) vehicle · nhtsa · backtested ↑ POWER TRAIN (17%) |
BASELINE | 16 | 0.93 | 0.86× | 0.23 | 29% | 4 |
| 8 | Mounjaro (tirzepatide) drug · fda_drug |
BASELINE | 16 | 0 | 0× | -365.4 | 54% | 0 |
| 9 | Honda CR-V (2023) vehicle · nhtsa · backtested ↑ STEERING (60%) |
BASELINE | 14 | 0.93 | 0.38× | -0.47 | 10% | 4 |
| 10 | Toyota RAV4 (2023) vehicle · nhtsa · backtested ↑ BACK OVER PREVENTION (33%) |
BASELINE | 10 | 0.7 | 0.69× | -0.23 | 14% | 3 |
| 11 | Toyota RAV4 (2024) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (33%) |
BASELINE | 10 | 0.7 | 0.45× | -0.47 | 13% | 3 |
| 12 | Beta Bionics iLet device · fda_device |
BASELINE | 10 | 0 | 0× | -793.1 | 23% | 0 |
| 13 | Jeep Grand Cherokee (2022) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (32%) |
BASELINE | 6 | 1.87 | 0.83× | 0 | 0% | 8 |
| 14 | Honda Prologue (2024) vehicle · nhtsa · backtested ↑ STEERING (27%) |
BASELINE | 6 | 5.83 | 0.44× | -1.87 | 2% | 25 |
| 15 | Tandem t:slim X2 Pump device · fda_device |
BASELINE | 5 | 0 | 0× | -2811.9 | 10% | 0 |
| 16 | Ford F-350 Crew Cab (2021) vehicle · nhtsa · backtested ↑ FUEL/PROPULSION SYSTEM (33%) |
BASELINE | 3 | 0.47 | 1× | 0 | 0% | 2 |
| 17 | Ford Mustang Mach-E (2021) vehicle · nhtsa · backtested ↑ ELECTRICAL SYSTEM (20%) |
BASELINE | 2 | 0.47 | 0.55× | -1.4 | 0% | 2 |
| 18 | Dexcom G7 CGM device · fda_device |
BASELINE | 0 | — | — | — | — | — |
| 19 | Medtronic MiniMed 780G device · fda_device |
BASELINE | 0 | 0 | 0× | -678.77 | 0% | 0 |
| 20 | Philips DreamStation CPAP device · fda_device |
BASELINE | 0 | 0 | 0× | -1785.23 | 0% | 0 |
| 21 | Ozempic (semaglutide) drug · fda_drug |
BASELINE | 0 | — | — | — | — | — |
| 22 | Wegovy (semaglutide) drug · fda_drug |
BASELINE | 0 | 0 | 0× | -413.7 | 0% | 0 |
| 23 | Humira (adalimumab) drug · fda_drug |
BASELINE | 0 | 0 | 0× | -129.03 | 0% | 0 |
| 24 | Eliquis (apixaban) drug · fda_drug |
BASELINE | 0 | — | — | — | — | — |
| 25 | Ford F-150 Lightning (2023) vehicle · nhtsa |
BASELINE | 0 | — | — | — | — | — |
Sources: CPSC SaferProducts · openFDA (drug & device adverse events) · NHTSA complaints.
Every flagged entity is cross-checked daily against real CPSC / FDA / NHTSA recall feeds. When a flagged product is later recalled, we publish the lead time.
Free weekly digest of the top rising-risk products. Retailers, insurers and class-action firms — see the paid feed/API/webhook tiers.